Should you buy Roche Holding AG stock? (PINK:RHHBY). Let's see how it does in our automated value investing analysis system.
Advantages | Disadvantages |
---|---|
|
|
RHHBY Price (Roche Holding AG stock price per share) |
$40.56 | |
PE Ratio versus Sector | 11% lower than other Healthcare stocks | |
PE Ratio versus Industry | 4% higher than other Drug Manufacturers - Major stocks | |
Free Cash Flow Jitter | 0% | |
Dividend Yield | 3% | Shares Shorted | 0 |
Based on our analysis, we believe that you should not buy Roche Holding AG right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.
Does Roche Holding AG have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.
Most Popular Articles
What are Broker Fees (and how to pay less)?
Facebook Stock Price and Value
What Does COVID-19 Mean for Stocks?
How to Make Money with Penny Stocks
What is a Good Annual Rate of Return?
What is Market Capitalization?